EUVIMEDEUVIMED entdecken
Open Access

ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network

Hongyan Qian, Rui Ji, Cheng Shen, Yinze Wei, Chenyi Sheng, Qichao Ni, Jing Pan, Yifan Chi, Huan You, Ying Miao, Minxin Shi, Xianghua Huang und 1 weitere

Aging · 2023

DOI: 10.18632/aging.205327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Hongyan Qian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center Nantong, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong 226361, China. Hauptthemen laut MEDLINE: Breast Neoplasms, X-linked Nuclear Protein, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsX-linked Nuclear ProteinDrug Resistance, NeoplasmFemaleHumansDoxorubicinGATA2 Transcription FactorGene Regulatory NetworksNerve Tissue ProteinsPaclitaxelErb-b2 Receptor Tyrosine KinasesTamoxifenZinc Finger Protein Gli3Receptors, Androgen

Stichwörter der Autor:innen

ATRXbiomarkerbreast cancerdrug resistancetranscription factor

Substanzen

DoxorubicinGATA2 Transcription FactorNerve Tissue ProteinsPaclitaxelErb-b2 Receptor Tyrosine KinasesTamoxifenX-linked Nuclear ProteinZinc Finger Protein Gli3Receptors, AndrogenATRX protein, human

Autor:innen und Institutionen

  • Cancer Research Center Nantong, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong 226361, China.
  • Department of Gynecology Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong 226361, China.
  • Department of Computer Science and Engineering, Tandon School of Engineering, New York University, Brooklyn, NY 11201, USA.
  • Department of Pathology, Affiliated Tumor Hospital of Nantong University, Nantong 226361, China.
  • Department of Breast Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China.
  • School of Medicine, Nantong University, Nantong 226001, China.

Zitieren

APA

Qian, H., Ji, R., Shen, C., Wei, Y., Sheng, C., Ni, Q., Pan, J., Chi, Y., You, H., Miao, Y., Shi, M., Huang, X., & Shen, A. (2023). ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network. Aging. https://doi.org/10.18632/aging.205327

Vancouver

Qian H, Ji R, Shen C, Wei Y, Sheng C, Ni Q, et al. ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network. Aging. 2023. doi:10.18632/aging.205327

BibTeX
@article{Qian2023,
  author = {Qian, Hongyan and Ji, Rui and Shen, Cheng and Wei, Yinze and Sheng, Chenyi and Ni, Qichao and Pan, Jing and Chi, Yifan and You, Huan and Miao, Ying and Shi, Minxin and Huang, Xianghua and Shen, Aiguo},
  title = {ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205327}
}
Kostenlos starten →